Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Jaguar Health, Inc. (JAGX) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Jaguar Health, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1585608.
Total stock buying since 2016: $911,563.
Total stock sales since 2016: $596,650.
Total stock option exercises since 2016: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 3 | $0 |
| 2024 | 0 | $0 | 0 | $0 | 6,541 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 10,016 | $0 |
| 2022 | 0 | $0 | 0 | $0 | 122,377 | $0 |
| 2021 | 15,936 | $39,998 | 444 | $775 | 0 | $0 |
| 2019 | 193,287 | $386,574 | 0 | $0 | 0 | $0 |
| 2018 | 41,232 | $34,991 | 325,615 | $595,875 | 0 | $0 |
| 2017 | 100,000 | $50,000 | 0 | $0 | 0 | $0 |
| 2016 | 160,000 | $400,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-05 | 0 | $0 | 0 | $0 | 3 | $0 |
| 2024-05 | 0 | $0 | 0 | $0 | 5,480 | $0 |
| 2024-04 | 0 | $0 | 0 | $0 | 1,061 | $0 |
| 2023-05 | 0 | $0 | 0 | $0 | 9,047 | $0 |
| 2023-04 | 0 | $0 | 0 | $0 | 969 | $0 |
| 2022-05 | 0 | $0 | 0 | $0 | 49,532 | $0 |
| 2022-04 | 0 | $0 | 0 | $0 | 72,845 | $0 |
| 2021-09 | 15,936 | $39,998 | 0 | $0 | 0 | $0 |
| 2021-06 | 0 | $0 | 444 | $775 | 0 | $0 |
| 2019-07 | 193,287 | $386,574 | 0 | $0 | 0 | $0 |
| 2018-10 | 25,000 | $15,000 | 0 | $0 | 0 | $0 |
| 2018-09 | 0 | $0 | 325,615 | $595,875 | 0 | $0 |
| 2018-07 | 16,232 | $19,991 | 0 | $0 | 0 | $0 |
| 2017-06 | 100,000 | $50,000 | 0 | $0 | 0 | $0 |
| 2016-02 | 160,000 | $400,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-17 | King Steven R. (See Remarks) | Option Ex | 1 | .00 | 0 |
| 2025-05-17 | Conte Lisa A (CEO and President) | Option Ex | 2 | .00 | 0 |
| 2024-05-17 | Chaturvedi Pravin R (Chief Scientific Officer) | Option Ex | 871 | .00 | 0 |
| 2024-05-17 | Wolin Jonathan S. (Chief of Staff, CCO & GC) | Option Ex | 871 | .00 | 0 |
| 2024-05-17 | Lizak Carol R. (Chief Financial Officer) | Option Ex | 431 | .00 | 0 |
| 2024-05-17 | King Steven R. (See Remarks) | Option Ex | 612 | .00 | 0 |
| 2024-05-17 | Conte Lisa A (CEO and President) | Option Ex | 2,695 | .00 | 0 |
| 2024-04-05 | Chaturvedi Pravin R (Chief Scientific Officer) | Option Ex | 134 | .00 | 0 |
| 2024-04-05 | Wolin Jonathan S. (Chief of Staff, CCO & GC) | Option Ex | 89 | .00 | 0 |
| 2024-04-05 | Lizak Carol R. (Chief Financial Officer) | Option Ex | 60 | .00 | 0 |
| 2024-04-05 | King Steven R. (See Remarks) | Option Ex | 178 | .00 | 0 |
| 2024-04-05 | Conte Lisa A (CEO and President) | Option Ex | 600 | .00 | 0 |
| 2023-05-17 | Chaturvedi Pravin R (Chief Scientific Officer) | Option Ex | 870 | .00 | 0 |
| 2023-05-17 | Wolin Jonathan S. (Chief of Staff, CCO & GC) | Option Ex | 871 | .00 | 0 |
| 2023-05-17 | Lizak Carol R. (Chief Financial Officer) | Option Ex | 431 | .00 | 0 |
| 2023-05-17 | King Steven R. (Chief of Sustainable Supply) | Option Ex | 611 | .00 | 0 |
| 2023-05-17 | Siegel Jonathan B. | Option Ex | 1,145 | .00 | 0 |
| 2023-05-17 | Bochnowski James J | Option Ex | 1,280 | .00 | 0 |
| 2023-05-17 | Micek John | Option Ex | 1,145 | .00 | 0 |
| 2023-05-17 | Conte Lisa A (CEO and President) | Option Ex | 2,694 | .00 | 0 |
| 2023-04-05 | Chaturvedi Pravin R (Chief Scientific Officer) | Option Ex | 44 | .00 | 0 |
| 2023-04-05 | Wolin Jonathan S. (Chief of Staff, CCO & GC) | Option Ex | 88 | .00 | 0 |
| 2023-04-05 | Lizak Carol R. (Chief Financial Officer) | Option Ex | 60 | .00 | 0 |
| 2023-04-05 | King Steven R. (Chief of Sustainable Supply) | Option Ex | 177 | .00 | 0 |
| 2023-04-05 | Conte Lisa A (CEO and President) | Option Ex | 600 | .00 | 0 |
| 2022-05-18 | Siegel Jonathan B. | Option Ex | 12,133 | .00 | 0 |
| 2022-05-18 | Divis Gregory J | Option Ex | 12,133 | .00 | 0 |
| 2022-05-18 | Bochnowski James J | Option Ex | 13,133 | .00 | 0 |
| 2022-05-18 | Micek John | Option Ex | 12,133 | .00 | 0 |
| 2022-04-05 | Chaturvedi Pravin R (Chief Scientific Officer) | Option Ex | 3,333 | .00 | 0 |
| 2022-04-05 | Wolin Jonathan S. (Chief of Staff, CCO & GC) | Option Ex | 6,666 | .00 | 0 |
| 2022-04-05 | Lizak Carol R. (Chief Financial Officer) | Option Ex | 4,513 | .00 | 0 |
| 2022-04-05 | King Steven R. (Chief of Sustainable Supply) | Option Ex | 13,333 | .00 | 0 |
| 2022-04-05 | Conte Lisa A (CEO and President) | Option Ex | 45,000 | .00 | 0 |
| 2021-09-13 | Lizak Carol R. (Chief Financial Officer) | Buy | 7,968 | 2.51 | 19,999 |
| 2021-09-13 | Conte Lisa A (CEO and President) | Buy | 7,968 | 2.51 | 19,999 |
| 2021-06-04 | Bochnowski James J (Director) | Sale | 152 | 1.74 | 264 |
| 2021-06-03 | Bochnowski James J (Director) | Sale | 292 | 1.75 | 511 |
| 2019-07-23 | Siegel Jonathan B. (Director) | Buy | 12,705 | 2.00 | 25,410 |
| 2019-07-23 | Bochnowski James J (Director) | Buy | 180,582 | 2.00 | 361,164 |
| 2018-10-04 | Siegel Jonathan B. (Director) | Buy | 25,000 | .60 | 15,000 |
| 2018-09-25 | Burford Capital Ltd | Sale | 325,615 | 1.83 | 595,875 |
| 2018-07-18 | Siegel Jonathan B. (Director) | Buy | 5,000 | 1.09 | 5,475 |
| 2018-07-18 | Conte Lisa A (CEO and President) | Buy | 1,500 | 1.11 | 1,668 |
| 2018-07-17 | Siegel Jonathan B. (Director) | Buy | 2,232 | 1.19 | 2,656 |
| 2018-07-16 | Siegel Jonathan B. (Director) | Buy | 7,500 | 1.36 | 10,192 |
| 2017-06-28 | Bochnowski James J (Director) | Buy | 100,000 | .50 | 50,000 |
| 2016-02-08 | Bochnowski James J (Director) | Buy | 160,000 | 2.50 | 400,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of JAGX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Jaguar Health, Inc. (symbol JAGX, CIK number 1585608) see the Securities and Exchange Commission (SEC) website.